You are invited to participate in survey which is being carried out by Alma Bermingham as part of the MEDISIGNS project.
The aim of the survey is to establish user preferences for the development of an iPhone/Android App for healthcare professionals, interpreters and d/Deaf, hard of hearing patients in medical settings.
MEDISIGNS is a European Commission funded project (Leonardo da Vinci) that runs from 2010-12. The promoter and co-ordinator is Interesource Group (Ireland) Limited and partners are: The Centre for Deaf Studies, Trinity College Dublin (Ireland); School of Sciences, University of Nicosia (Cyprus); Department of Sign Language Studies, Department of Linguistics, University of Stockholm (Sweden), School of Management and Languages, Heriot-Watt University (Scotland) and the Foundation for the Promotion of Entrepreneurship (Poland).
MEDISIGNS represents a ground-breaking initiative that focuses on providing a better understanding of the impact that interpreted interaction in medical contexts has within the framework of a blended learning programme for Deaf people, interpreters and those in the medical profession. There has been very limited research on the experiences of Deaf people in interpreted (or not) healthcare settings in Europe. Thus, a key aim is to benchmark aspects of the Irish experience vis-à-vis our European project partners.
The core goal of the MEDISIGNS project is the creation of CPD training in a blended learning environment for interpreters/ medical staff and Deaf people as well as developing tools, such as the App, to improve access to healthcare through improved communications.
All data collected is anonymous. Results will feed into reports regarding interpreter provision in medical settings and help in planning continuous professional development courses for Irish interpreters in the field, and in training. Results will also be used as part of Alma Bermingham's Master dissertation.
Completion of this survey should take an estimated 6 minutes.
We thank you for your time.
For further information about MEDISIGNS see: http://www.medisignsproject.eu